Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

The post-truth behind the asthma-COPD overlap and the orbit of Mercury: lessons from the CHACOS study.

Pérez de Llano L, López-Campos JL, Cosío BG.

Arch Bronconeumol. 2018 Feb 17. pii: S0300-2896(18)30019-X. doi: 10.1016/j.arbres.2018.01.004. [Epub ahead of print] English, Spanish. No abstract available.

2.

Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco.

Golpe R, Sanjuán-López P, Martín-Robles I, González-Juanatey C, Pérez-de-Llano L, López-Campos JL.

Lung. 2018 Feb 12. doi: 10.1007/s00408-018-0095-9. [Epub ahead of print]

PMID:
29435736
3.

Predictors of one-year mortality after hospitalization for an exacerbation of COPD.

Esteban C, Castro-Acosta A, Alvarez-Martínez CJ, Capelastegui A, López-Campos JL, Pozo-Rodriguez F.

BMC Pulm Med. 2018 Jan 25;18(1):18. doi: 10.1186/s12890-018-0574-z.

4.

Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study.

Calle Rubio M, Rodríguez Hermosa JL, Soler-Cataluña JJ, López-Campos JL, Alcazar Navarrete B, Soriano JB, Rodríguez Gónzalez-Moro JM, Fuentes Ferrer ME, Miravitlles M; y el Grupo Epoconsul.

Arch Bronconeumol. 2018 Jan 17. pii: S0300-2896(17)30437-4. doi: 10.1016/j.arbres.2017.11.015. [Epub ahead of print] English, Spanish.

5.

Understanding of COPD among final-year medical students.

Mohigefer J, Calero-Acuña C, Marquez-Martin E, Ortega-Ruiz F, Lopez-Campos JL.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 28;13:131-139. doi: 10.2147/COPD.S138539. eCollection 2018.

6.

Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency.

Matamala N, Lara B, Gomez-Mariano G, Martínez S, Retana D, Fernandez T, Silvestre RA, Belmonte I, Rodriguez-Frias F, Vilar M, Sáez R, Iturbe I, Castillo S, Molina-Molina M, Texido A, Tirado-Conde G, Lopez-Campos JL, Posada M, Blanco I, Janciauskiene S, Martinez-Delgado B.

Am J Respir Cell Mol Biol. 2017 Dec 12. doi: 10.1165/rcmb.2017-0179OC. [Epub ahead of print]

PMID:
29232161
7.

Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study.

Calle Rubio M, López-Campos JL, Soler-Cataluña JJ, Alcázar Navarrete B, Soriano JB, Rodríguez González-Moro JM, Fuentes Ferrer ME, Rodríguez Hermosa JL; EPOCONSUL Study.

Respir Res. 2017 Dec 2;18(1):200. doi: 10.1186/s12931-017-0685-8.

8.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003.

PMID:
29169740
9.

Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.

Casanova C, Celli BR, de-Torres JP, Martínez-Gonzalez C, Cosio BG, Pinto-Plata V, de Lucas-Ramos P, Divo M, Fuster A, Peces-Barba G, Calle-Rubio M, Solanes I, Aguero R, Feu-Collado N, Alfageme I, De Diego A, Romero A, Balcells E, Llunell A, Galdiz JB, Marin M, Moreno A, Cabrera C, Golpe R, Lacarcel C, Soriano JB, López-Campos JL, Soler-Cataluña JJ, Marin JM.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701162. doi: 10.1183/13993003.01162-2017. Print 2017 Nov.

PMID:
29167301
10.

Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.

Golpe R, Martín-Robles I, Sanjuán-López P, Pérez-de-Llano L, González-Juanatey C, López-Campos JL, Arellano-Orden E.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 1;12:2639-2646. doi: 10.2147/COPD.S141068. eCollection 2017.

11.

The variability of respiratory symptoms and associated factors in COPD.

Miravitlles M, Izquierdo JL, Esquinas C, Pérez M, Calle M, López-Campos JL, Rodríguez González-Moro JM, Casanova C, Esteban C, de Lucas P.

Respir Med. 2017 Aug;129:165-172. doi: 10.1016/j.rmed.2017.06.017. Epub 2017 Jun 26.

PMID:
28732827
12.

Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit.

Buess M, Schilter D, Schneider T, Maurer M, Borer H, Thurnheer R, Köhler E, Junker L, Jahn K, Grob M, Rüdiger J, Geiser T, Helfenstein E, Solèr M, Fiechter R, Sigrist T, Brun P, Barandun J, Koltai E, López-Campos JL, Hartl S, Roberts M, Schumann DM, Tamm M, Stolz D.

Respiration. 2017;94(4):355-365. doi: 10.1159/000477911. Epub 2017 Jul 19.

PMID:
28719893
13.

Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review.

Lopez-Campos JL, Calero-Acuña C, Márquez-Martín E, Quintana Gallego E, Carrasco-Hernández L, Abad Arranz M, Ortega Ruiz F.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 23;12:1867-1876. doi: 10.2147/COPD.S132962. eCollection 2017.

14.

Accuracy of COPD Diagnosis During an Admission: The European Perspective.

Lopez-Campos JL, Castro-Acosta A, Pozo-Rodriguez F, Hartl S, Roberts CM.

Chest. 2017 Jun;151(6):1396-1397. doi: 10.1016/j.chest.2017.01.044. No abstract available.

PMID:
28599931
15.

Home mechanical ventilation for stable COPD in GOLD 2017: What are we ventilating?

Lopez-Campos JL, Caballero-Eraso C, Barrot-Cortés E.

Respirology. 2017 Nov;22(8):1497-1499. doi: 10.1111/resp.13091. Epub 2017 May 30. No abstract available.

16.

Major Changes in the Spanish COPD Guidelines (GesEPOC) 2017: Crossing Bridges.

Lopez-Campos JL, Marquez-Martín E, Ortega-Ruiz F.

Arch Bronconeumol. 2017 Jun;53(6):291-292. doi: 10.1016/j.arbres.2017.04.006. Epub 2017 May 12. English, Spanish. No abstract available.

17.

Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?

Cosío BG, Pérez de Llano L, Lopez Viña A, Torrego A, Lopez-Campos JL, Soriano JB, Martinez Moragon E, Izquierdo JL, Bobolea I, Callejas J, Plaza V, Miravitlles M, Soler-Catalunya JJ; on behalf of the CHACOS study group.

Eur Respir J. 2017 May 1;49(5). pii: 1602397. doi: 10.1183/13993003.02397-2016. Print 2017 May.

PMID:
28461299
18.

Seasonal variability in clinical care of COPD outpatients: results from the Andalusian COPD audit.

López-Campos JL, Abad Arranz M, Calero-Acuña C, Romero-Valero F, Ayerbe-García R, Hidalgo-Molina A, Aguilar-Pérez-Grovas RI, García-Gil F, Casas-Maldonado F, Caballero-Ballesteros L, Sánchez-Palop M, Pérez-Tejero D, Segado Soriano A, Calvo-Bonachera J, Hernández-Sierra B, Doménech A, Arroyo-Varela M, González-Vargas F, Cruz-Rueda JJ.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 3;12:785-792. doi: 10.2147/COPD.S121885. eCollection 2017.

19.

Recent lung cancer mortality trends in Europe: effect of national smoke-free legislation strengthening.

López-Campos JL, Ruiz-Ramos M, Fernandez E, Soriano JB.

Eur J Cancer Prev. 2017 Apr 4. doi: 10.1097/CEJ.0000000000000354. [Epub ahead of print]

PMID:
28379885
20.

Overdiagnosis of COPD: precise definitions and proposals for improvement.

Fernández-Villar A, Soriano JB, López-Campos JL.

Br J Gen Pract. 2017 Apr;67(657):183-184. doi: 10.3399/bjgp17X690389. No abstract available.

PMID:
28360069
21.

Triple Therapy vs. Triple Therapy in COPD.

Lopez-Campos JL, Marquez-Martín E, Ortega-Ruiz F.

Arch Bronconeumol. 2017 Aug;53(8):419-420. doi: 10.1016/j.arbres.2017.01.020. Epub 2017 Mar 14. English, Spanish. No abstract available.

22.

The importance of rural living and sex in exposure to biomass smoke.

Lopez-Campos JL, Fernandez Villar A, Casamor R.

Arch Bronconeumol. 2017 May;53(5):290. doi: 10.1016/j.arbres.2017.01.005. Epub 2017 Feb 24. English, Spanish. No abstract available.

23.

Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study.

Calle Rubio M, Alcázar Navarrete B, Soriano JB, Soler-Cataluña JJ, Rodríguez González-Moro JM, Fuentes Ferrer ME, López-Campos JL.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 25;12:417-426. doi: 10.2147/COPD.S124482. eCollection 2017.

24.

Evaluation of symptomatic patients without airflow obstruction: back to the future.

Lopez-Campos JL, Alcazar B.

J Thorac Dis. 2016 Dec;8(12):E1657-E1660. doi: 10.21037/jtd.2016.12.103. No abstract available.

25.

Specific networks of plasma acute phase reactants are associated with the severity of chronic obstructive pulmonary disease: a case-control study.

Arellano-Orden E, Calero-Acuña C, Cordero JA, Abad-Arranz M, Sánchez-López V, Márquez-Martín E, Ortega-Ruiz F, López-Campos JL.

Int J Med Sci. 2017 Jan 15;14(1):67-74. doi: 10.7150/ijms.16907. eCollection 2017.

26.

Chronic obstructive pulmonar disease: The Hunt for the Right Classification.

Ortega Ruiz F, Márquez Martín E, López-Campos JL.

Arch Bronconeumol. 2017 Mar;53(3):91-92. doi: 10.1016/j.arbres.2016.11.014. Epub 2017 Jan 3. English, Spanish. No abstract available.

27.

How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?

Beeh KM, Burgel PR, Franssen FME, Lopez-Campos JL, Loukides S, Hurst JR, Fležar M, Ulrik CS, Di Marco F, Stolz D, Valipour A, Casserly B, Ställberg B, Kostikas K, Wedzicha JA.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):139-149. doi: 10.1164/rccm.201609-1794CI. Review.

PMID:
27922741
28.

Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Barreiro E, Bustamante V, Curull V, Gea J, López-Campos JL, Muñoz X.

J Thorac Dis. 2016 Oct;8(10):E1122-E1135. Review.

29.

Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit.

Ruparel M, López-Campos JL, Castro-Acosta A, Hartl S, Pozo-Rodriguez F, Roberts CM.

ERJ Open Res. 2016 Mar 5;2(1). pii: 00034-2015. eCollection 2016 Jan.

30.

Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort.

Cosio BG, Soriano JB, López-Campos JL, Calle M, Soler JJ, de-Torres JP, Marín JM, Martínez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I; CHAIN study.

PLoS One. 2016 Sep 29;11(9):e0160770. doi: 10.1371/journal.pone.0160770. eCollection 2016. Erratum in: PLoS One. 2016 Nov 2;11(11):e0166257.

31.

Beta-blockers and COPD: the show must go on.

Lopez-Campos JL, Márquez-Martín E, Casanova C.

Eur Respir J. 2016 Sep;48(3):600-3. doi: 10.1183/13993003.01222-2016. No abstract available.

32.

IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).

Pastor MD, Nogal A, Molina-Pinelo S, Quintanal-Villalonga Á, Meléndez R, Ferrer I, Romero-Romero B, De Miguel MJ, López-Campos JL, Corral J, García-Carboner R, Carnero A, Paz-Ares L.

J Thorac Oncol. 2016 Dec;11(12):2183-2192. doi: 10.1016/j.jtho.2016.07.026. Epub 2016 Aug 12.

33.

Occupational and Biomass Exposure in Chronic Obstructive Pulmonary Disease: Results of a Cross-Sectional Analysis of the On-Sint Study.

López-Campos JL, Fernández-Villar A, Calero-Acuña C, Represas-Represas C, López-Ramírez C, Fernández VL, Casamor R; en nombre de los investigadores del estudio On-Sint.

Arch Bronconeumol. 2017 Jan;53(1):7-12. doi: 10.1016/j.arbres.2016.04.013. Epub 2016 Jul 16. English, Spanish.

34.

Frequent or Persistent Exacerbations: Identifying The Real Problem.

Lopez-Campos JL, Calero-Acuña C, Márquez-Martín E.

Arch Bronconeumol. 2016 Dec;52(12):577-578. doi: 10.1016/j.arbres.2016.05.019. Epub 2016 Jun 30. English, Spanish. No abstract available.

35.

Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?

Hartl S, Lopez-Campos JL.

Eur Respir J. 2016 Jul;48(1):281-2. doi: 10.1183/13993003.00885-2016. No abstract available.

36.

Determinants for changing the treatment of COPD: a regression analysis from a clinical audit.

López-Campos JL, Abad Arranz M, Calero Acuña C, Romero Valero F, Ayerbe García R, Hidalgo Molina A, Aguilar Perez-Grovas RI, García Gil F, Casas Maldonado F, Caballero Ballesteros L, Sánchez Palop M, Pérez-Tejero D, Segado A, Calvo Bonachera J, Hernández Sierra B, Doménech A, Arroyo Varela M, González Vargas F, Cruz Rueda JJ.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 2;11:1171-8. doi: 10.2147/COPD.S103614. eCollection 2016.

37.

The role of air pollution in COPD and implications for therapy.

Lopez-Campos JL, Marquez-Martin E, Soriano JB.

Expert Rev Respir Med. 2016 Aug;10(8):849-59. doi: 10.1080/17476348.2016.1191356. Epub 2016 Jun 9.

PMID:
27192169
38.

Cigarette Smoke Decreases the Maturation of Lung Myeloid Dendritic Cells.

Arellano-Orden E, Calero-Acuña C, Moreno-Mata N, Gómez-Izquierdo L, Sánchez-López V, López-Ramírez C, Tobar D, López-Villalobos JL, Gutiérrez C, Blanco-Orozco A, López-Campos JL.

PLoS One. 2016 Apr 8;11(4):e0152737. doi: 10.1371/journal.pone.0152737. eCollection 2016.

39.

Guideline Adherence in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Results from a Clinical Audit.

López-Campos JL, Abad Arranz M, Calero-Acuña C, Romero-Valero F, Ayerbe-García R, Hidalgo-Molina A, Aguilar-Pérez-Grovas RI, García-Gil F, Casas-Maldonado F, Caballero-Ballesteros L, Sánchez-Palop M, Pérez-Tejero D, Segado A, Calvo-Bonachera J, Hernández-Sierra B, Doménech A, Arroyo-Varela M, González-Vargas F, Cruz-Rueda JJ.

PLoS One. 2016 Mar 17;11(3):e0151896. doi: 10.1371/journal.pone.0151896. eCollection 2016.

40.

Factors Associated with Depression in COPD: A Multicenter Study.

Martinez Rivera C, Costan Galicia J, Alcázar Navarrete B, Garcia-Polo C, Ruiz Iturriaga LA, Herrejón A, Ros Lucas JA, García-Sidro P, Tirado-Conde G, López-Campos JL, Mayoralas Alises S, de Miguel-Díez J, Esquinas C, Miravitlles M.

Lung. 2016 Jun;194(3):335-43. doi: 10.1007/s00408-016-9862-7. Epub 2016 Mar 1.

PMID:
26932809
41.

Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.

Lopez-Campos JL, Calero-Acuña C, Lopez-Ramirez C, Abad-Arranz M, Márquez-Martín E, Ortega-Ruiz F, Arellano E.

Biomark Med. 2016;10(2):109-22. doi: 10.2217/bmm.15.87. Epub 2016 Jan 14. Review.

PMID:
26808692
42.

Mortality from cystic fibrosis in Europe: 1994-2010.

Quintana-Gallego E, Ruiz-Ramos M, Delgado-Pecellin I, Calero C, Soriano JB, Lopez-Campos JL.

Pediatr Pulmonol. 2016 Feb;51(2):133-42. doi: 10.1002/ppul.23337. Epub 2015 Nov 19.

PMID:
26584153
43.

Clinical Audits in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Workflow.

López-Campos JL, Abad Arranz M, Calero Acuña C, Romero Valero F, Ayerbe García R, Hidalgo Molina A, Aguilar Pérez-Grovas RI, García Gil F, Casas Maldonado F, Caballero Ballesteros L, Sánchez Palop M, Pérez-Tejero D, Segado A, Calvo Bonachera J, Hernández Sierra B, Doménech A, Arroyo Varela M, González Vargas F, Cruz Rueda JJ.

PLoS One. 2015 Nov 6;10(11):e0141856. doi: 10.1371/journal.pone.0141856. eCollection 2015.

44.

Combined alpha-1-antitrypsin deficiency and mannose-binding lectin deficiency.

López-Ramírez C, López-Campos JL.

Arch Bronconeumol. 2016 Mar;52(3):174. doi: 10.1016/j.arbres.2015.09.002. Epub 2015 Oct 28. English, Spanish. No abstract available.

45.

Global burden of COPD.

López-Campos JL, Tan W, Soriano JB.

Respirology. 2016 Jan;21(1):14-23. doi: 10.1111/resp.12660. Epub 2015 Oct 23. Review.

46.

Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.

Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, Roberts CM.

Eur Respir J. 2016 Jan;47(1):113-21. doi: 10.1183/13993003.01391-2014. Epub 2015 Oct 22.

47.

Differences in the use of spirometry between rural and urban primary care centers in Spain.

Márquez-Martín E, Soriano JB, Rubio MC, Lopez-Campos JL; 3E project.

Int J Chron Obstruct Pulmon Dis. 2015 Aug 17;10:1633-9. doi: 10.2147/COPD.S86074. eCollection 2015.

48.

Mixed COPD-asthma Phenotype: ACOS or CAOS? A Reflection on Recent Guidelines and Recommendations.

Fernández-Villar A, López-Campos JL.

Arch Bronconeumol. 2016 May;52(5):277-8. doi: 10.1016/j.arbres.2015.07.005. Epub 2015 Aug 20. English, Spanish. No abstract available.

49.

Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort.

Cosio BG, Soriano JB, López-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP, Marín JM, Martínez-Gonzalez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I, Casanova C; CHAIN Study.

Chest. 2016 Jan;149(1):45-52. doi: 10.1378/chest.15-1055. Epub 2016 Jan 6.

PMID:
26291753
50.

What pulmonologists think about the asthma-COPD overlap syndrome.

Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015.

Supplemental Content

Loading ...
Support Center